WallStreetZenWallStreetZen

NYSEMKT: NBY
Novabay Pharmaceuticals Inc Stock Ownership - Who owns Novabay Pharmaceuticals?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Novabay Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Poplar Point Capital Partners LP10% Owner2025-04-08300$0.47
$139.50Buy
Poplar Point Capital Partners LP10% Owner2025-04-044,538$0.52
$2.37kBuy
Poplar Point Capital Partners LP10% Owner2025-04-0322,976$0.56
$12.94kBuy
Poplar Point Capital Partners LP10% Owner2025-04-02917$0.58
$531.86Buy
Poplar Point Capital Partners LP10% Owner2025-04-0119,915$0.59
$11.65kBuy
Poplar Point Capital Partners LP10% Owner2025-03-3121,654$0.59
$12.78kBuy
Poplar Point Capital Partners LP10% Owner2025-03-2849,400$0.61
$30.23kBuy
Poplar Point Capital Partners LP10% Owner2025-03-27600$0.61
$365.40Buy
Poplar Point Capital Partners LP10% Owner2025-03-2718,504$0.62
$11.38kBuy
Poplar Point Capital Partners LP10% Owner2025-03-2613,292$0.61
$8.09kBuy

1 of 4

NBY insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NBY insiders and whales buy or sell their stock.

NBY Shareholders

What type of owners hold Novabay Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ramin Najafi327.22%19,031,699$11.42MInsider
China Pioneer Pharma Holdings Ltd251.36%14,619,468$8.77MInsider
Pioneer Pharma Hong Kong Co Ltd209.66%12,194,077$7.32MInsider
Pioneer Pharma Singapore Pte Ltd89.21%5,188,421$3.11MInsider
Jian Ping Fu68.77%4,000,000$2.40MInsider
Xinzhou Li48.17%2,801,743$1.68MInsider
Naqu Area Pioneer Pharma Co Ltd48.14%2,800,000$1.68MInsider
Mark M. Sieczkarek19.89%1,156,883$694.13kInsider
Poplar Point Capital Partners LP17.54%1,020,300$612.18kInsider
Robert R. Tufts17.49%1,017,066$610.24kInsider

1 of 3

NBY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NBY0.25%99.75%Net BuyingNet Buying
CERO17.02%82.98%Net Selling
INM4.05%56.06%Net Selling
CELZ1.71%2.02%Net SellingNet Selling
ARTL1.05%25.41%
View Top Biotech Stocks

Novabay Pharmaceuticals Stock Ownership FAQ

Who owns Novabay Pharmaceuticals?

Novabay Pharmaceuticals (NYSEMKT: NBY) is owned by 2.87% institutional shareholders, 1,130.99% Novabay Pharmaceuticals insiders, and 0.00% retail investors. Ramin Najafi is the largest individual Novabay Pharmaceuticals shareholder, owning 19.03M shares representing 327.22% of the company. Ramin Najafi's Novabay Pharmaceuticals shares are currently valued at $11.42M.

If you're new to stock investing, here's how to buy Novabay Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.